Kenyan women to take part in monthly HIV pill trial

The fight against HIV is set to receive a major boost if the monthly pill, whose trials Kenyan women will participate in, is proven effective. It is likely to replace PrEP which is taken daily.

Photo credit: Pool | Nation Media Group

What you need to know:

  • Islatravir pill is taken once per month to prevent HIV transmissions through sex and has been termed as a game changer if its efficacy is proven.
  • The third phase of its trial will involve 4,000 HIV-uninfected women aged 16-45, from South Africa, Uganda, Kenya, Malawi, Eswatini, Zimbabwe and Zambia.
  • If the results of the trials turn positive, Islatravir is likely to replace Pre-Exposure Prophylaxis (PrEP) which is taken daily.

The fight against HIV is set to receive a major boost if the monthly pill, whose trials Kenyan women will participate in, is proven effective.

Welcome!

You're all set to enjoy unlimited Prime content.